Skip to Content

TV TV L2 L2 (Lamivudine and Zidovudine 150 mg / 300 mg)

Pill with imprint TV TV L2 L2 is White, Elliptical / Oval and has been identified as Lamivudine and Zidovudine 150 mg / 300 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Lamivudine/zidovudine is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Lamivudine/zidovudine 150 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TV TV L2 L2

Lamivudine and Zidovudine

Imprint:
TV TV L2 L2
Strength:
150 mg / 300 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA Inc.
Inactive Ingredients:
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
magnesium stearate
microcrystalline cellulose
polyethylene glycol 400
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
42291-0363 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide